Новости Фонда

Французское предупреждение о депрессии и суицидальных идеях, вызванных пропецией, вызывает волну внимания у СМИ

Dec. 19, 2017 Dear Friends: France is taking PFS very seriously. On Oct. 26, the French National Agency for Drug Safety (ANSM) issued a warning that “Changes in mood, particularly depression, and suicidal ideation, have been reported by patients taking Propecia.” The agency—France’s equivalent of the US Food and Drug Administration—noted that “finasteride treatment should […]

Нормативное обновление: Европейское агентство по лекарственным препаратам рекомендует добавлять депрессию и суицидальные идеи к этикетке финастерида

Aug. 10, 2017 Dear Friends: On August 4, CEO John Santmann wrote in his 2017 Annual Address, “Recent events in Europe and Asia have given me hope that, before this decade is out, we’ll see the day when no man on Earth is prescribed finasteride without ample warning of its many potential dangers.” Then he […]

Годовой адрес Фонда PFS 2017

Aug. 4, 2017 Dear Friends: Recent events in Europe and Asia have given me hope that, before this decade is out, we’ll see the day when no man on earth is prescribed finasteride without ample warning of its many potential dangers. On May 24, the UK’s equivalent of the US Food and Drug Administration, the […]

Нормативно-правовое обновление: Корея предписывает изменение метки Пропеции на основании сообщений о депрессии и суицидальных идеях

July 15, 2017 Dear Friends: On July 4, the Korean Ministry of Food and Drug Safety (MFDS) announced it will revise the warning label on Propecia and its generic versions to include depression and suicidal ideation. The move by South Korea’s equivalent of the US Food and Drug Administration came just six weeks after the […]

Нормативно-правовое обновление: Корея предписывает изменение метки Пропеции на основании сообщений о депрессии и суицидальных идеях

May 26, 2017 Dear Friends: The UK’s equivalent of the US Food and Drug Administration, the Medicines and Healthcare Products Regulatory Agency (MHRA), has issued a drug safety update on finasteride. The May 24 document, titled Finasteride: rare reports of depression and suicidal thoughts, states: Some men have reported episodes of depressive illness in association with […]

Периферическая нервная система, вовлеченная в пациентов с PFS с тяжелой ЭД, демонстрирует новое исследование

SOMERSET, N.J., April 18, 2017 – Post-finasteride syndrome (PFS) patients suffer from altered levels of critical brain-function regulators, including neuroactive steroids, according to a new clinical study published in The Journal of Steroid Biochemistry and Molecular Biology. Titled Neuroactive Steroid Levels and Psychiatric and Andrological Features in Post-Finasteride Patients, the three-year study also uncovered evidence […]

132/5000 Исследование Эпидемиологии Школы Медицины им. Файнберга предполагает, что десятки тысяч случаев PFS у молодых мужчин принимают Финастерид для выпадения волос

SOMERSET, N.J., March 9, 2017 – More than one percent of young men who took finasteride for 206 days or longer developed persistent erectile dysfunction (PED) that lasted an average of 4.2 years after drug discontinuation, according to a new study published today in PeerJ. In all, researchers examined the electronic medical records (EMR) of […]

«Основополагающие нейробиологические нарушения» существуют у потребителей финастерида с персистирующей сексуальной дисфункцией, предполагает клиническое исследование

SOMERSET, N.J., Sept. 29, 2016 – Men who experience persistent sexual dysfunction after discontinuing finasteride have “neurobiological abnormalities,” suggests a new study published in The Journal of Clinical Endocrinology & Metabolism. Among those abnormalities is neural circuitry that overlaps with functional abnormalities identified in men suffering from “major depression.” Titled Characteristics of Men Who Report […]

Программа поддержки объединяет пациентов ПФС по всему миру

СОМЕРСЕТ, штат Нью-Джерси, 21 сентября 2016 г. — Фонд «Постфинастеридного синдрома» запустил программу взаимной поддержки пациентов с ПФС.Фонд «Постфинастеридного синдрома» запустил программу взаимной поддержки пациентов с ПФС. Любой пациент ПФС или член его семьи, желающий принять участие в программе, могут загрузить форму PFS Patient Support, заполнить её и отправить по электронной почте по адресу social@pfsfoundation.org. […]

Годовой адрес Фонда PFS 2016

Aug. 4, 2016 Dear Friends: I began last year’s annual address by letting you know how encouraged I was that the National Institutes of Health had not only added PFS to its Genetic and Rare Diseases Information Center but linked to our website. Now I’m equally encouraged to note a similar milestone, achieved exactly one […]